Persistent URL of this record https://hdl.handle.net/1887/119343
In Collections
This item can be found in the following collections:
![Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis
- All authors
- Smolen, J.S.; Boers, M.; Abadie, E.C.; Breedveld, F.C.; Emery, P.; Bardin, T.; Goel, N.; Ethgen, D.J.; Avouac, B.P.; Durez, P.; Flamion, B.; Laslop, A.; Miossec, P.; Reiter, S.; Reginster, J.Y.; Task Force Grp Respect Ethics & Ex
- Date
- 2011-01-17
- Journal
- Rheumatology